The 2030 Agenda for Sustainable Development officially acknowledges viral hepatitis as a global health and development priority and commits to combating viral hepatitis. Viral hepatitis was included as a focus area in the health related goal – Goal 3.3 – with world leaders pledging to ‘combat’ it by 2030. In response, World Health Organization drafted the Global Viral Hepatitis Strategy which was then subsequently adopted in 2016 by all of its Member States. This Strategy carries ambitious targets which if reached will reduce the number of deaths by 65% and increase treatment rates from 1% to 80%.

The Global Viral Hepatitis Strategy is deeply integrated in HBI-DC's organizational action plan. Our best-practice methodologies are continuously developed and refined in order to meet the Strategy's goals and objectives.

Hepatitis B Initiative of Washington DC (HBI-DC) is a registered 501(c)3 nonprofit organization. Our organization’s mission is to mobilize communities to prevent liver diseases caused by viral hepatitis among Asian Americans and Pacific Islanders, African immigrants, and other high-risk groups.

Our Contact

1725 I Street NW, Suite 300
Washington, DC 20006

(571) 274-0021

(202) 792-6882

EIN# 20-5841637